At a Glance
| Myristicin | Diphenhydramine | |
|---|---|---|
| Class | Deliriant | Deliriant |
| Common Dose (oral) | 200–500 mg | 200–400 mg |
| Total Duration | 13–24 hrs | 2.3–7 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Myristicin and Diphenhydramine is classified as dangerous. Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure
Myristicin, a Deliriant, and Diphenhydramine, a Deliriant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Deliriants, meaning they share a common pharmacological foundation. They share 48 documented effects in common, with 22 effects unique to Myristicin and 41 unique to Diphenhydramine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Myristicin | Diphenhydramine | |
|---|---|---|
| Class | Deliriant | Deliriant |
| Common Dose (oral) | 200–500 mg | 200–400 mg |
| Total Duration | 13–24 hrs | 2.3–7 hrs |
| Routes | oral | oral |
| Effects |
| 70 documented |
| 89 documented |
| Interaction | Dangerous | |
| Level | Myristicin | Diphenhydramine |
|---|---|---|
| Threshold | — mg | 25 mg |
| Light | 50–200 mg | 100–200 mg |
| Common | 200–500 mg | 200–400 mg |
| Strong | 500–800 mg | 400–700 mg |
| Heavy | 800 mg | 700 mg |
Myristicin
Diphenhydramine
Compounding anticholinergic effects; severe risk of hyperthermia, cardiac arrhythmia, and organ failure